Register

Browse Companies:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
0 1 2 3 4 5 6 7 8 9
Top 10 Penny Stocks
Symbol: Price: Chg %: Volume:
DNAX 0.0002 0 561555858
GNCP 0.00015 50 296849895
ECOB 0.0002 0 222230679
TNEN 0.0002 0 151701253
FPFI 0.0002 -33.33 130207236
SFOR 0.0002 0 117607216
EVSV 0.0002 -33.33 88657579
BBDA 0.0002 0 64215850
MELY 0.0002 100 38362114
PLKD 0.0002 0 33152066
FOGC 0.0002 0 28214668
AVEW 0.0002 0 18696611
CIRC 0.0002 0 18281100
WNBD 0.0002 0 15145581
ANDI 0.0002 0 13113309
TADF 0.0002 0 12042000
YTRV 0.0002 0 11849998
WPUR 0.0002 0 9555000
HLNT 0.0002 0 9362512
NEGS 0.0002 0 6490000
BCAP 0.0002 0 5506669
EGOH 0.0002 0 4665001
CDOI 0.0002 0 4001000
ADPAR 0.0002 0 2026600
EWPI 0.0002 0 1698682
EKWX 0.0002 0 1555000
PTAH 0.0002 -0 1548650
SKYF 0.0002 0 1510714
IDCN 0.0002 0 1420305
STAU 0.0002 0 1399800

0001 Stocks

Sort By: Date Alphabetically

MultiCell Technologies, Inc. (MCET) Loses Momentum After Recent Climb

Thumbnail
MultiCell Technologies, Inc. (MCET) spiked last Monday after a press release came out, announcing the company had been granted a U.S. patent covering novel drug compositions and platform technologies used for fighting virus infection and cancer. MCET climbed by 57% in price on a 750 thousand share volume at a $846,1 thousand trade value. These were the highest numbers for the company in over five months and the first significant increase since late March. The next day, however, the ticker suffered... more

Bergio International, Inc. (BRGO) Files 10-Q To Report No Progress

Thumbnail
On Thursday, Bergio International, Inc. (BRGO) managed to timely submit its 10-Q for the period ended June 30, 2014. The next day, BRGO issued a press release in which it commented on the results from the report. As can be seen in the filing, the financials did not account for much progress made by the company: Cash: $65,1 thousand Total current assets: $2,1 million Total current liabilities: $879,1 thousand Revenues: $361,1 thousand Net loss: $580,1 thousand In the press release from August 15, BRGO... more

Puramed Bioscience, Inc. (PMBS) Back To Triple Zero Bottom

Thumbnail
Puramed Bioscience, Inc. (PMBS) ended last week with a slide down, lowering the price back to the $0.0001 mark. PMBS's efforts have had no success in maintaining a long-lasting interest in the company. The price of PMBS' stock has been low throughout recent events. The announcements about the company's plans for future development have been insufficient to halt the decline. PMBS' downfall began after an 8-K issued on July 11 reported about a number of decisions that shareholders seemingly did not approve... more

mPhase Technologies, Inc. (XDSL) Sinks Further Down

Thumbnail
The efforts mPhase Technologies, Inc. (XDSL) has made to attract investors' interest lately have had no reaction on the market. XDSL recently reported a growth in revenues in the last quarter of its fiscal year ended June 30, 2014. The company stated in a press release issued on August 5 that its revenues have grown by approximately 6% compared to the previous quarter. We can take a look at XDSL's 10-Q for the period ended March 31, 2014 to see what this would translate into: Cash: $87,4 thousand Total... more
First 1 2 3 4 5 6 7 8 9 10 >> Last